首页> 外国专利> PROCESS FOR TREATING BLINDNESS WITH HUMAN NEURONAL HNT CELLS

PROCESS FOR TREATING BLINDNESS WITH HUMAN NEURONAL HNT CELLS

机译:治疗人类神经HNT细胞失明的方法

摘要

Disclosed herein is the treatment of vision loss in a mammal by transplanting an effective amount of hNT-Neuron cells. The treatment can be accomplished by injecting the cells into the retinal area of the eye. Additionally, the cells can be injected into the visual cortex of the brain. Conditions to be treated are vision loss due to optic nerve damage, including glaucoma, optic nerve sheath meningioma and glioma, Graves' ophthalmopathy, benign or malignant orbital tumors, metastatic lesions, tumors arising from the adjacent paranasal sinuses or middle cranial fossa, giant pituitary adenomas, brain tumors or abscesses, cerebral trauma or hemorrhage, meningitis, arachnoidal adhesions, pseudotumor cerebri, cavernous sinus thrombosis, dural sinus thrombosis, encephalitis, space-occupying brain lesions, severe hypertensive disease or pulmonary emphysema.
机译:本文公开了通过移植有效量的hNT-神经元细胞治疗哺乳动物视力丧失的方法。可以通过将细胞注入眼睛的视网膜区域来完成治疗。另外,可以将细胞注射到大脑的视觉皮层中。待治疗的疾病是由于视神经损害引起的视力丧失,包括青光眼,视神经鞘膜脑膜瘤和神经胶质瘤,格雷夫斯眼病,良性或恶性眼眶肿瘤,转移性病变,由相邻的鼻旁窦或颅中窝引起的肿瘤,巨大的垂体腺瘤,脑肿瘤或脓肿,脑外伤或出血,脑膜炎,蛛网膜粘连,假瘤脑,海绵窦血栓形成,硬脑膜窦血栓形成,脑炎,占位性脑损伤,严重高血压疾病或肺气肿。

著录项

  • 公开/公告号AT307483T

    专利类型

  • 公开/公告日2005-11-15

    原文格式PDF

  • 申请/专利权人 LAYTON BIOSCIENCE INC.;

    申请/专利号AT19980906485T

  • 发明设计人 SNABLE GARY L.;

    申请日1998-02-12

  • 分类号A01N63/00;A61P25/00;A61P27/02;

  • 国家 AT

  • 入库时间 2022-08-21 21:36:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号